Yoav Zeif
Analyst · Credit Suisse. Please go ahead
Thank you, Yonah. Good morning, everyone and thank you for joining us. Our results this quarter demonstrate the ongoing solid business performance and fiscal health of Stratasys. We delivered our highest third quarter revenue in seven years as well as five consecutive quarters of positive earnings, demonstrating our unique capabilities to generate profitable growth, and we believe we can continue generating sustained operating profitability for the foreseeable future, assuming no further material deterioration of the broader economic environment. It is a compelling time to be a leader in 3D printing. In fact, many of the challenges facing our target industries today, are the same factors that ultimately justify accelerating the transition from traditional to additive manufacturing. This includes the ability to adapt rapidly and cost effectively to logistics bottlenecks, higher transportation costs, new sustainability requirements and faster product innovation times. Stratasys continues to expand our customer reach across our technologies and our vision of the future of additive manufacturing is more robust than ever. We continue to have strong engagement with both our installed base and new customers for our leading FDM and PolyJet offering as well as our three newer technologies. However, the opportunities that we have, also come with some obstacles in the current macro space. Customers are facing challenges today that are impacting their purchasing behavior. The market has slowed, resulting in longer sales cycles and occasional deferral of orders. To that point, we remain laser-focused on controlling what we can to be best positioned to effectively execute sustained profitable growth. Importantly, we have a broad global diverse set of offerings across a multitude of systems and materials. The steady contributions from our organic technologies and the incremental revenues from our new technologies enable us to deliver consistent growth with improving margins. We also enhanced our results through a relentless focus on costs. We are tightly managing our cost structure as evidenced by the ongoing improved efficiency in our OpEx spending, reflected in the year-over-year 130 basis points improvement this quarter in OpEx as a percentage of revenue. We expect to continue finding efficiencies in the business to further demonstrate the resiliency of our model. As a reminder, our main OEM business is to deliver polymer-based 3D printing solutions through hardware, materials, software and services, with a focus on shifting more of our revenues from prototyping to manufacturing. Revenue in our OEM business, this quarter, was up approximately 10% year-over-year at constant currency. Overall, revenues were up 7.8%, excluding divestitures and on a constant currency basis, driven by our highest third quarter system revenue in six years, which grew 18.9% adjusted for FX and divestiture compared to the third quarter of 2021. We believe that the contribution from our new technologies, SaaS, P3 and NEO, has more than doubled our addressable market and opened up new use cases and opportunities to replace traditional manufacturing across verticals. We are expanding and improving our line of FDM systems and materials as well as starting to see the positive progress on P3 and SaaS, our more recently launched mass production solution. FDM delivered solid growth this quarter and is still the largest technology in 3D printing today. A recent proof point of the continued demand for FDM is a repeat sale this third quarter to a global automotive OEM for more of our industrial manufacturing grade F900 system. Furthermore, to fund additional growth, we ended the quarter with a strong balance sheet that includes no debt -- this continues to support our growth through organic investments as well as accretive acquisition opportunities that we uncover, including early-stage but highly compelling technology driven businesses that we believe will contribute to our growth by leveraging our infrastructure. Now, let me turn to some of the exciting achievements and milestones reached since the end of the first half of 2022. We believe that a comprehensive materials offering that competes with and even improve on traditional manufacturing is key for taking 3D printing into true production applications. We are very excited to update you about our progress on this material journey across all of our technologies. In August, we agreed to acquire Covestro's additive manufacturing materials business, which includes R&D facilities and activities, global development and sales teams across Europe, the US, China, a portfolio of 60 additive manufacturing materials and an extensive IP portfolio. With hundreds of patents and patents pending, Covestro is an example of a business we believe can thrive as it leverages our infrastructure and relationships. It has been an important part of our third-party materials ecosystem, as we are already a distributor of their Somos resins that are available for use in our Neo and Origin One 3D printers. Adding this business to the Stratasys portfolio provides us ability to offer more complete solutions to customers, accelerate next-generation material development and expand our already differentiated materials offering in term of lithography, DLP resins and powders. Closing remains on track for the end of the first quarter of 2023 and is expected to be immediately accretive. For FDM, we announced availability of 13 new validated materials and our open AM software. This includes several materials from Covestro and partners like Victrex and Kimya, it also includes several existing materials now available in new colors. For materials like ULTEM 9085 thermoplastic, this is significant, because it makes it easier for our customers to use 3D printed production parts in more customer-facing applications, where static matters such as in commercial aircraft and train and car interiors. These 13 materials represent a tremendous acceleration in the pace of new materials innovation for FDM, opening up new applications far faster than ever before. We also introduced two new validated industrial materials for the Origin One printer in the quarter. P3 Stretch 475 is a new resin from our partners, Henkel Loctite that adds a softer elastomer to our portfolio, which our customers have requested. For example, we have a large automotive customer that has been using the material for end use door seals. In addition, we introduced P3 Deflect 120, which is our first validated material for Evonik. P3 Deflect 120 is designed to stay strong at high temperatures ideal for applications like molds in manufacturing. We are also excited to have reached key milestones in the dental industry which is the largest manufacturing target market in 3D printing today in terms of the amount of materials consumed, and it continues to grow. I'm happy to share that Stratasys has recently received FDA 510(k) approval of a new revolutionary resin for our J5 DentaJet that we believe will be a disruptive growth driver for us in the dental industry. 3D printing of dental is particularly exciting as it is only in its ground floor stage. It is a $5 billion addressable market today and growing, and we plan to take a meaningful share over time. We are currently working with several leading industry partners to prepare for its commercialization and look forward to officially launching the solution at LMT Lab Day in Chicago at the end of this coming February. This is a great example of how we are expanding the PolyJet end market universe, and believe that it has a promising future for non-prototype and use parts in medical, dental and fashion applications. In addition to these strategic initiatives, we invested in one company and acquired another that will enhance our capabilities in the area of artificial intelligence for 3D printing. Both reflect our strategic plan to incubate innovative technologies by bringing them under our umbrella, cultivating their advancement and positioning them to contribute to our overall long-term growth, and both will be available to our customers in 2023. First, we invested $10 million out of $15 million raised by Medtech startup Axial3D. Axial3D AI-powered cloud-based 3D printing platform enables healthcare providers to easily segment CT and MRI scans for anatomic models at a fraction of the cost and time of other solutions. 3D printed model created with our digital anatomy and J5 MediJet systems are used for pre-surgical planning in many leading hospitals to improve surgery success rates and patient recovery time. We are now working with Axial3D on a joint offering that we believe will remove barriers to entry for the majority of hospitals in many of our key markets, allowing our solution to truly become a standard part of patient care. We look forward to sharing more at the upcoming RSNA trade show later this year. Second, we acquired Riven, a cloud-based software company for additive manufacturing. We know Riven well, having watched them grow as one of our connectivity partners. Their cloud-based solution will be fully integrated into our GrabCAD additive manufacturing platform. Riven Technology helps customers weekly inspect diagnosed and automatically correct deviations between CAD5 and actual printed parts, within a closed loop additive manufacturing process. This means – every step in the process is interconnected from inspection to diagnosis to correction, the latest version in testing uses artificial intelligence to actually predict and readjust model changes in advance. The result is more accurate production runs in much less time, weeks or even months of potential improvement. And at a lower cost, key areas for focus for the manufacturing industry. These are just two examples of companies joining our platform that we believe will help drive our innovation vision forward. To sum up, we are laying meaningful foundation for further growth and we are proud of the expansion of our capabilities this quarter through new technologies and materials that will drive our industry leadership for the long term. I will now turn the call over to our CFO, Eitan Zamir, to share the financial results and update our outlook for the rest of 2022. Eitan?